))
Theranostics in the Clinic: What’s Working, What’s Missing, and What’s Next
Manage episode 488125665 series 3664252
Content provided by World Molecular Imaging Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by World Molecular Imaging Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode, Dr. Lilja Solnes (Johns Hopkins) and Dr. Martin Pomper (UT Southwestern) explore the current landscape of theranostics in clinical practice, from the early days of targeted radiopharmaceuticals to today’s breakthroughs and future directions. They discuss the success of agents like Lutathera and Pluvicto, the importance of preclinical models, the rise of alpha emitters, and the potential of combination therapies. With candid reflections on what’s working, what’s missing, and how to bridge the gap between research and patient care, this conversation offers deep insights into the evolving role of molecular imaging and therapy.
7 episodes
Share
